U.Ok.’s CDC Group pares stake in Equitas Holdings


Get real time updates directly on you device, subscribe now.

The U.K.’s development finance institution CDC Group has pruned its stake in Equitas Holdings Ltd. by 2.61% through sale of more than 89 lakh shares in the open market earlier this week, according to a filing.

“We have on February 25, 2021, sold (in open market) 89,30,410 equity shares of Equitas Holdings Ltd., constituting 2.61% of the paid-up share capital of Equitas Holdings Ltd.,” CDC Group plc said in the filing.

The disclosures are required under SEBI’s regulation on substantial acquisition of shares and takeovers, it added.

Before the sale of shares, CDC Group held 7.84% stake in Equitas Holdings, equivalent to 2,67,91,230 equity shares. Hence, the total shareholding of the U.K.’s development finance institution has now come down to 5.23%, equivalent to 1,78,60,820 equity shares.

CDC Group is a public shareholder in Equitas Holdings, as per BSE data. Equitas Holdings is the promoter of the south-India based Equitas Small Finance Bank.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.


A one-stop-shop for seeing the latest updates, and managing your preferences.


We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

A letter from the Editor

Dear subscriber,

Thank you!

Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.

The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.

We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.

Suresh Nambath

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More